title: Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation.
authors.affiliation: Department of Internal Medicine (Cancer Research), University of Essen Medical School, West German Cancer Center, Essen, Germany. ralf.hilger@uni-essen.de
authors.forename: R A
authors.initials: RA
authors.lastname: Hilger
authors.forename: J
authors.initials: J
authors.lastname: Baumgart
authors.forename: M E
authors.initials: ME
authors.lastname: Scheulen
authors.forename: R
authors.initials: R
authors.lastname: Trenschel
authors.forename: D
authors.initials: D
authors.lastname: Strumberg
authors.forename: S
authors.initials: S
authors.lastname: Seeber
authors.forename: D W
authors.initials: DW
authors.lastname: Beelen
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D002066:Busulfan / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006207:Half-Life; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008657:Metabolic Clearance Rate; D019653:Myeloablative Agonists / Q000627:therapeutic use; D014018:Tissue Distribution; D019172:Transplantation Conditioning
chemical_list: D018906:Antineoplastic Agents, Alkylating; D019653:Myeloablative Agonists; D003520:Cyclophosphamide; C018404:treosulfan; D002066:Busulfan